CVB homepage

The Autus pulmonary heart valve is adjustable so it can grow with congenital heart patients as they age.

Children with congenital heart disease outgrow their replacement valves, requiring repeat open-heart surgeries. The Autus can be expanded using a transcatheter procedure.

The Recor Medical renal denervation (RDN) system, pictured here at TCT 2024, and Medtronic’s Symplicity Spyral RDN system have received transitional pass-through payments from CMS for 2025.

The establishment of dedicated CPT codes represents an important step in the broader reimbursement for renal denervation to treat uncontrolled hypertension.

cardiologists heart doctors heart research heart data

Blocking the enzyme succinate dehydrogenase can flip a metabolic switch in adult mice to prompt cardiomyocyte regeneration.

There has been an explosion of interest in cardiology in diagnosing and treating hypertrophic cardiomyopathy (HCM) since the the FDA approval of the first HCM drug treatment Camzyos (mavacamten). Booth photo from the American Heart Association (AHA) 2022 meeting. Photo by Dave Fornell

The drug is now the only FDA-approved therapy for the treatment of obstructive HCM in a pediatric population.

Brian Ghoshhajra, MD, MBA, FSCCT, Medical director of radiology and clinical operations for integrated imaging services, Mass General Bringham, and an associate professor of radiology at Harvard Medical School, explains how his center integrated artificial intelligence (AI) into its radiology and cardiovascular imaging workflow.

At Mass General Brigham, advanced algorithms help clinicians spend more time focused on what matters most.

Mediterranean diet keto diet

A new ACC scientific statement looks at how eating well can help with the prevention and management of CVD. Plant-based foods as well as healthy fats and proteins are recommended over foods high in refined starches, added sugars and unhealthy fats. 

Innovation at work

Cardiologists have always wanted a better way to identify heart patients in need of care early in their course of disease. Artificial intelligence may be the tool physicians have been waiting for. 

Sponsored by Medtronic